INSUBCONTINENT EXCLUSIVE:
At 1:00 pm, the NSE Nifty 50 index was up 0.02 per cent at 17,237.65Shares crept higher on Wednesday, with pharmaceutical stocks leading the
derivatives) and it's December-end..
There is volatility and we are also coming close to some amount of stability in the markets," said Anita Gandhi, a whole-time director at
valuations and as the Omicron variant of COVID-19 rapidly spreads across the globe."Overall volumes have fallen and markets are
consolidating in thin volumes
A mild rally over the year-end also cannot be ruled out because of net asset value-based buying," Gandhi said.The Nifty pharma index was the
several drugmakers including Dr Reddy's Labs, Aurobindo Pharma, Cipla and Sun Pharmaceuticals signed non-exclusive voluntary licensing
agreements with Merck to manufacture and supply molnupiravir in India.Dr Reddy's and Sun Pharma were the top gainers in the Nifty 50
Tuesday strengthened rules for companies going public, potentially slowing some planned new issues, as it seeks to protect retail investors
after a record year of initial public offerings (IPOs).Asian stocks slipped, following a mixed Wall Street session as the region's
staff and is published from a syndicated feed.)
